- Cell Biology
- Product Type
- Research Area
- New Products
- About Tocris
- Contact Us
Bruton's Tyrosine Kinase (BTK) is member of the Tec family that is critically important for the growth, differentiation and activation of myeloid-, mast- and B-cells. BTK is initially activated by membrane localization which is stimulated by the generation of PIP3.
|Cat No||Product Name / Activity|
|5592||LCB 03-0110 dihydrochloride|
|Potent BTK inhibitor; also inhibits c-Src, DDR2 and Syk|
|Potent, selective BTK inhibitor|
|Potent BTK inhibitor|
|Potent inhibitor of interleukin-2 inducible T cell kinase (ITK). Also inhibits BTK|
|Selective inhibitor of BTK|
Bruton's Tyrosine Kinase (BTK) is member of the Tec family that is critically important for the growth, differentiation and activation of myeloid-, mast- and B-cells. BTK is activated firstly by membrane localization stimulated by PIP3 generation, and subsequently, by transphosphorylation of Tyr-551 by Src family kinases.
Activated BTK is involved in the phosphorylation of a number of signaling molecules involved in the PLCγ, JNK and p38 MAPK pathways, leading to Ca2+ mobilization, mRNA stabilization and the induction of NF-κB and AP-1 transcription factors. BTK activity is negatively regulated by a number of proteins including inhibitor of BTK (IBTK), Sab and c-Cbl. Mutations in this enzyme are known in humans and result in the immunological disorder X-linked agammaglobulemia.
Tocris offers the following scientific literature for Bruton's Tyrosine Kinase to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.